November 13, 2020
InCarda Therapeutics Presents Positive New Data from Phase 2 Study of InRhythm™ in Patients with Paroxysmal Atrial Fibrillation at American Heart Association Scientific Sessions 2020
Media
November 10, 2020
Fusion Pharmaceuticals Announces Third Quarter 2020 Financial Results And Business Update
November 10, 2020
Pulmonx Reports Third Quarter 2020 Financial Results
November 09, 2020
Targovax announces poster at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 06, 2020
Interim report July-September 2020
November 05, 2020
BONESUPPORT HOLDING AB (publ) – Publishes Q3 2020 Interim report
November 05, 2020
Targovax ASA: third quarter 2020 results
November 05, 2020
Aprea Therapeutics Reports Third Quarter 2020 Financial Results and Provides Update on Business Operations
November 04, 2020
Oncopeptides Announces that New Data for Melflufen is Accepted for Presentation at the Annual American Society of Hematology Meeting
November 04, 2020
Correction notice of press release – Q3 2020 Interim Report – ZUBSOLV® guiding 2020
